Saravanan Matheshwaran

Saravanan Matheshwaran

Auto-generated profile, based on publicly available information

Saravanan Matheshwaran

Indian Institute of Technology Kanpur

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Nucleic Acids Research
Verified
Journal Article
Closed access
MSMatheshwaran Saravanan
Matheshwaran Saravanan
JBJanusz M. Bujnicki
Janusz M. Bujnicki
ICIwona A. Cymerman
Iwona A. Cymerman
DRDesirazu N. Rao
Desirazu N. Rao
VNValakunja Nagaraja
Valakunja Nagaraja
The restriction endonuclease (REase) R.KpnI is an orthodox Type IIP enzyme, which binds to DNA in the absence of metal ions and cleaves the DNA sequence 5'-GGTAC--C-3' in the presence of Mg2+ as shown generating 3' four base overhangs. Bioinformatics analysis reveals that R.KpnI contains a betabetaalpha-Me-finger fold, which is characteristic of many HNH-superfamily endonucleases, including homing endonuclease I-HmuI, structure-specific T4 endonuclease VII, colicin E9, sequence non-specific Serratia nuclease and sequence-specific homing endonuclease I-PpoI. According to our homology model of R.KpnI, D148, H149 and Q175 correspond to the critical D, H and N or H residues of the HNH nucleases. Substitutions of these three conserved residues lead to the loss of the DNA cleavage activity by R.KpnI, confirming their importance. The mutant Q175E fails to bind DNA at the standard conditions, although the DNA binding and cleavage can be rescued at pH 6.0, indicating a role for Q175 in DNA binding and cleavage. Our study provides the first experimental evidence for a Type IIP REase that does not belong to the PD...D/EXK superfamily of nucleases, instead is a member of the HNH superfamily.

3 December 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MSMatheshwaran Saravanan
Matheshwaran Saravanan
JWJochen Wuerges
Jochen Wuerges
DBDaniel Bose
Daniel Bose
EMElizabeth A. McCormack
Elizabeth A. McCormack
NCNicola J. Cook
Nicola J. Cook
DWDale B. Wigley
Dale B. Wigley
Actin-related protein Arp8 is a component of the INO80 chromatin remodeling complex. Yeast Arp8 (yArp8) comprises two domains: a 25-KDa N-terminal domain, found only in yeast, and a 75-KDa C-terminal domain (yArp8CTD) that contains the actin fold and is conserved across other species. The crystal structure shows that yArp8CTD contains three insertions within the actin core. Using a combination of biochemistry and EM, we show that Arp8 forms a complex with nucleosomes, and that the principal interactions are via the H3 and H4 histones, mediated through one of the yArp8 insertions. We show that recombinant yArp8 exists in monomeric and dimeric states, but the dimer is the biologically relevant form required for stable interactions with histones that exploits the twofold symmetry of the nucleosome core. Taken together, these data provide unique insight into the stoichiometry, architecture, and molecular interactions between components of the INO80 remodeling complex and nucleosomes, providing a first step toward building up the structure of the complex.

1 June 2019 in Ceramics International
Verified
Journal Article
Closed access
ABArjak Bhattacharjee
Arjak Bhattacharjee
AGAnshul Gupta
Anshul Gupta
MVMadhu Verma
Madhu Verma
PMPrem Anand Murugan
Prem Anand Murugan
PSPradyut Sengupta
Pradyut Sengupta
KBKantesh Balani
Kantesh Balani

1 January 2020 in Ceramics International
Verified
Journal Article
Closed access
ABArjak Bhattacharjee
Arjak Bhattacharjee
AGAnshul Gupta
Anshul Gupta
MVMadhu Verma
Madhu Verma
MAMurugan Prem Anand
Murugan Prem Anand
PSPradyut Sengupta
Pradyut Sengupta
KBKantesh Balani
Kantesh Balani

24 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IQIrfan Qayoom
Irfan Qayoom
RVRahul Verma
Rahul Verma
PMPrem Anand Murugan
Prem Anand Murugan
Deepak RainaDeepak Raina
Deepak Raina
ATArun Kumar Teotia
Arun Kumar Teotia
AKAshok Kumar
Ashok Kumar
Long term multiple systemic antibiotics form the cornerstone in the treatment of bone and joint tuberculosis, often combined with local surgical eradication. Implanted carriers for local drug delivery have recently been introduced to overcome some of the limitations associated with conventional treatment strategies. In this study, we used a calcium sulphate hemihydrate (CSH)/nanohydroxyapatite (nHAP) based nanocement (NC) biomaterial as a void filler as well as a local delivery carrier of two standard of care tuberculosis drugs, Rifampicin (RFP) and Isoniazid (INH). We observed that the antibiotics showed different release patterns where INH showed a burst release of 67% and 100% release alone and in combination within one week, respectively whereas RFP showed sustained release of 42% and 49% release alone and in combination over a period of 12 weeks, respectively indicating different possible interactions of antibiotics with nHAP. The interactions were studied using computational methodology, which showed that the binding energy of nHAP with RFP was 148 kcal/mol and INH was 11 kcal/mol, thus varying substantially resulting in RFP being retained in the nHAP matrix. Our findings suggest that a biphasic ceramic based drug delivery system could be a promising treatment alternative to bone and joint TB.

2 March 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
GSGaneshan Shakambari
Ganeshan Shakambari
ABAnand Kumar Birendranarayan
Anand Kumar Birendranarayan
MLMaria Joseph Angelaa Lincy
Maria Joseph Angelaa Lincy
SRSameer Kumar Rai
Sameer Kumar Rai
QAQuazi Taushif Ahamed
Quazi Taushif Ahamed
VPVaralakshmi Perumal
Varalakshmi Perumal
Bacillus tequilensis PV9W, a marine bacterial isolate obtained from Gulf of Mannar, Rameswaram, India, produced glutaminase free L-asparaginase which was purified to homogeneity with a significant increase (13 fold) in specific activity. The apparent Km (0.045 ± 0.013 mM) and Vmax (7.465 ± 0.372 μmol ml−1 min−1) values of this purified L-asparaginase was identified and it was found that the maximum activity of the L-asparaginase was at a pH 8.5 and a temperature of 35 °C. The enzyme is a mixed α/β protein and the influence of different effectors were documented. The purified L-asparaginase had effective acrylamide degradation activity (6 IU per ml) and cytotoxic activity against HeLa cell lines with an IC50 of 0.036 ± 0.009 IU per ml. Furthermore, the purified enzyme showed p53 dependent G2 arrest in HeLa cells analyzed by FACS and was hemocompatible. Thus, this study highlights the marine isolate PV9W as a potential source for glutaminase free L-asparaginase with industrial as well as pharmaceutical applications. This study also paves a way for a possible therapeutic drug with the least amount of side effects.